Featured Research

from universities, journals, and other organizations

Neurotransmission Machinery Visualized For The First Time

Date:
September 24, 1998
Source:
Howard Hughes Medical Institute
Summary:
The classic image of communication between brain cells shows a neurotransmitter crossing the synapse and binding to receptors on the surface of a neighboring neuron. Yet, scientists have had only a murky picture of the events within the secreting neuron that trigger this neurotransmitter release.

September 23,1998—The classic image of communication between brain cells shows a neurotransmitter crossing the synapse and binding to receptors on the surface of a neighboring neuron. Yet, scientists have had only a murky picture of the events within the secreting neuron that trigger this neurotransmitter release.

Related Articles


Now, a group of researchers led by Axel T. Brunger, a Howard Hughes Medical Institute (HHMI) investigator at Yale University has deciphered and produced the first glimpses of the molecular machinery that propels neurotransmitters into the synapse. The key players are a family of proteins called SNAREs (Soluble NSF Attachment protein REceptor). These proteins haven't changed much through evolution; SNAREs play a similar role in the secretions of even primitive life forms like yeast.

In neurons, the merging of these mostly amorphous proteins into a highly structured and charged complex precipitates neurotransmitter release. Formation of the complex fuses vesicles—tiny sacs carrying the neurotransmitter inside the neuron—with the cell membrane, spewing the neurotransmitter into the synapse. Such vesicle fusion occurs millions of times daily in each of the human brain's 100 billion neurons. So understanding vesicle fusion promises to shed light on processes like learning and memory, and may lead to improved treatments for brain disorders.

"It's sort of like merging two soap bubbles into one, but hardly that simple," explained R. Bryan Sutton, an HHMI associate in Brunger's laboratory. Sutton, Brunger and their colleagues report the elucidation of the synaptic fusion complex's intricate molecular structure in the September 24, 1998, issue of Nature.

The researchers used ultra-bright x-ray radiation from a synchrotron facility funded by the U.S. Department of Energy to illuminate the tiny protein crystals and determine the shape of the complex, atom-by-atom. They then created computer reconstructions that provide clues about how this pivotal protein may accomplish its mission.

Within the neuron, vesicles fill up with neurotransmitters, such as dopamine or serotonin. They then travel out into the neuron's extensions (axons), where they dock at the membrane and await an electrochemical signal to merge. At this moment the SNAREs form a complex.

Like other known fusion mechanisms, such as those used by viruses to infect cells, synaptic fusion employs a protein agent to meld two membranes. But unlike viral mechanisms, in which the fusion protein simply changes its shape, the very assembly of the synaptic fusion protein itself leads to the union of vesicle and cell membrane.

This assembly likely begins when two SNARE proteins in the cell's membrane, SNAP-25 and syntaxin, join together, Brunger says. This two-part complex is then joined by a third protein from the vesicle, synaptobrevin, in a configuration that sets up electrical and chemical forces that could promote membrane fusion. In addition, highly flexible helical structures in the complex, prone to twisting and bending, could cause strains that physically deform fatty layers within the two membranes, allowing them to mix. The complex's highly grooved surface, with distinct electrically and chemically polarized regions, could also be important for fusion and for the binding of regulatory factors affecting neurotransmission, say the researchers.

"The complex may act sort of like a winch to drive the vesicle down into the neuron's membrane," said Brunger. "Diseases such as tetanus and botulism take advantage of the fusion machinery by attacking these ties between neurotransmitter-filled vesicles and the neuron's membrane, effectively cutting the winch cable and causing neurological symptoms."

Advances in knowledge about the protein complex's structure could be of potential use in designing new medications for disorders of brain function, suggests Brunger.


Story Source:

The above story is based on materials provided by Howard Hughes Medical Institute. Note: Materials may be edited for content and length.


Cite This Page:

Howard Hughes Medical Institute. "Neurotransmission Machinery Visualized For The First Time." ScienceDaily. ScienceDaily, 24 September 1998. <www.sciencedaily.com/releases/1998/09/980924075145.htm>.
Howard Hughes Medical Institute. (1998, September 24). Neurotransmission Machinery Visualized For The First Time. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/1998/09/980924075145.htm
Howard Hughes Medical Institute. "Neurotransmission Machinery Visualized For The First Time." ScienceDaily. www.sciencedaily.com/releases/1998/09/980924075145.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins